UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

British journal of cancer, 2008-05, Vol.98 (10), p.1608-1613

2008

Link zum Volltext

Verfügbarkeit prüfen

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

Transfusion (Philadelphia, Pa.), 1996-07, Vol.36 (7), p.601-610

1996

Link zum Volltext

Verfügbarkeit prüfen

Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy

Journal of clinical oncology, 1992-09, Vol.10 (9), p.1460-1469

1992

Link zum Volltext

Verfügbarkeit prüfen

The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies

Bone marrow transplantation (Basingstoke), 1991-02, Vol.7 (2), p.139-143

1991

Link zum Volltext

Verfügbarkeit prüfen

Phase I-II trial of high-dose epirubicin in patients with lymphoma

Cancer research (Chicago, Ill.), 1987-12, Vol.47 (23), p.6393-6396

1987

Link zum Volltext

Verfügbarkeit prüfen

Phase I-II study of epirubicin in multiple myeloma

Cancer research (Chicago, Ill.), 1988-11, Vol.48 (21), p.6246-6248

1988

Link zum Volltext

Verfügbarkeit prüfen

Serum cathepsin B (CB) levels are prognostic in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18036-18036

2007

Link zum Volltext

Verfügbarkeit prüfen

Serum-free estradiol (E2) levels are prognostic in men with chemotherapy-naive advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7683-7683

2007

Link zum Volltext

Verfügbarkeit prüfen

Single-agent compared to combination first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) of 2

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7637-7637

2007

Link zum Volltext

Verfügbarkeit prüfen

Medical resource utilization (MRU) and costs associated with paclitaxel poliglumex (PPX) compared to gemcitabine (Gem) or vinorelbine (Vin) in non-small cell lung cancer (NSCLC) patients

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18172-18172

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of paclitaxel poliglumex (PPX) /carboplatin (C) for 1st line induction and maintenance therapy of stage III/IV ovarian or primary peritoneal carcinoma

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.5012-5012

2005

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of paclitaxel poliglumex (PPX) in combination with cisplatin (CIS) for patients (pts) with advanced cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2089-2089

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase I evaluation of paclitaxel poliglumex (PPX) administered weekly for patients with advanced cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2043-2043

2005

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel poliglumex (PPX) and concurrent radiation for treatment of patients with esophageal or gastric cancer: A dose-ranging study

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4065-4065

2005

Link zum Volltext

Verfügbarkeit prüfen

Perforation of an Unsuspected Cecal Granulocytic Sarcoma during Therapy with Granulocyte-Macrophage Colony-Stimulating Factor

The New England journal of medicine, 1990-02, Vol.322 (5), p.337-338

1990

Link zum Volltext

Verfügbarkeit prüfen

Continuity of research outcomes: The correlation of bench toxicity mechanisms to clinical outcomes—are they dependable?

American journal of kidney diseases, 2002-11, Vol.40 (5), p.1109-1109

Oldham, Fred B.

2002

Link zum Volltext

Verfügbarkeit prüfen

"Limited proteolysis," a new bleeding syndrome with circulating fibrinogen fragments

The Journal of laboratory and clinical medicine, 1971-11, Vol.78 (5), p.846

1971

Link zum Volltext

Verfügbarkeit prüfen

Perforation of an unsuspected cecal granulocytic sarcoma during therepy with granulocyte-macrophage colony-stimulating factor

The New England journal of medicine, 1990-01, Vol.322 (5), p.337-338

1990

Link zum Volltext

Verfügbarkeit prüfen

Treatment of normal individuals with granulocyte-colony-stimulating factor : donor experiences and the effects on peripheral blood CD3+ cell counts and on the collection of peripheral blood stem cells

Transfusion (Philadelphia, PA), 1996, Vol.36 (7), p.601-610

1996

Link zum Volltext

Verfügbarkeit prüfen

Total ionizing dose effects in MOS oxides and devices

IEEE transactions on nuclear science, 2003-06, Vol.50 (3), p.483-499

2003

Link zum Volltext
IEEE_Xplore

The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness

Journal of affective disorders, 2020-03, Vol.264, p.98-106

2020

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

The New England journal of medicine, 2019-02, Vol.380 (7), p.617-628

2019

Link zum Volltext

Verfügbarkeit prüfen

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

The New England journal of medicine, 2019-10, Vol.381 (18), p.1718-1727

2019

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension

Chest, 2019-10, Vol.156 (4), p.724-732

2019

Link zum Volltext

Verfügbarkeit prüfen

Discovery of three strongly lensed quasars in the Sloan Digital Sky Survey

Monthly notices of the Royal Astronomical Society. Letters, 2018-06, Vol.477 (1), p.L70-L74

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(77)
Humans
(71)
Female
(52)
Male
(44)
Biological And Medical Sciences
(33)
Middle Aged
(32)
Adult
(29)
Medical Sciences
(27)
Aged
(23)
Oncology
(16)
Physical Sciences
(15)
Technology
(15)
Adolescent
(13)
Animals
(13)
General & Internal Medicine
(12)
Child
(11)
Engineering
(11)
Engineering, Electrical & Electronic
(10)
Pharmacology. Drug Treatments
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy

The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies

Phase I-II trial of high-dose epirubicin in patients with lymphoma

Phase I-II study of epirubicin in multiple myeloma

Serum cathepsin B (CB) levels are prognostic in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2

Serum-free estradiol (E2) levels are prognostic in men with chemotherapy-naive advanced non-small cell lung cancer (NSCLC) and performance status (PS) 2

Single-agent compared to combination first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) of 2

Medical resource utilization (MRU) and costs associated with paclitaxel poliglumex (PPX) compared to gemcitabine (Gem) or vinorelbine (Vin) in non-small cell lung cancer (NSCLC) patients

Phase II study of paclitaxel poliglumex (PPX) /carboplatin (C) for 1st line induction and maintenance therapy of stage III/IV ovarian or primary peritoneal carcinoma

A phase I study of paclitaxel poliglumex (PPX) in combination with cisplatin (CIS) for patients (pts) with advanced cancer

Phase I evaluation of paclitaxel poliglumex (PPX) administered weekly for patients with advanced cancer

Paclitaxel poliglumex (PPX) and concurrent radiation for treatment of patients with esophageal or gastric cancer: A dose-ranging study

Perforation of an Unsuspected Cecal Granulocytic Sarcoma during Therapy with Granulocyte-Macrophage Colony-Stimulating Factor

Continuity of research outcomes: The correlation of bench toxicity mechanisms to clinical outcomes—are they dependable?

"Limited proteolysis," a new bleeding syndrome with circulating fibrinogen fragments

Perforation of an unsuspected cecal granulocytic sarcoma during therepy with granulocyte-macrophage colony-stimulating factor

Treatment of normal individuals with granulocyte-colony-stimulating factor : donor experiences and the effects on peripheral blood CD3+ cell counts and on the collection of peripheral blood stem cells

Total ionizing dose effects in MOS oxides and devices

The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension

Discovery of three strongly lensed quasars in the Sloan Digital Sky Survey

Suchergebnisse filtern